Clinical Trial Update: O6-benzylguanine and Carmustine in Treating Patients With Stage IA-IIA Cutaneous T-cell Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating O6-benzylguanine with Carmustine for Stage IA-IIA cutaneous T-cell lymphoma; the study was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous T-cell Lymphoma

Drugs mentioned

• Carmustine (BiCNU) (carmustine)
• O6-Benzylguanine (O6-Benzylguanine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Stage I Cutaneous T-cell Non-Hodgkin Lymphoma | Phase 1 | Status: TERMINATED